These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8482234)

  • 1. [Abdominal obesity. The metabolic syndrome, arteriosclerosis and mortality].
    Wirth A; Krone W
    Dtsch Med Wochenschr; 1993 Apr; 118(16):595-601. PubMed ID: 8482234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic syndrome. A new challenge for preventive medicine].
    Rett K; Wicklmayr M
    Dtsch Med Wochenschr; 1993 Oct; 118(39):1407-11. PubMed ID: 8404491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertension and multimetabolic syndrome].
    Suba I; Halmos T; Kautzky L; Jakab A
    Orv Hetil; 1993 Feb; 134(8):395-9. PubMed ID: 8441528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Syndrome "X"].
    Chabot V
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):858-63. PubMed ID: 8372281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance. A syndrome responsible for various cardiovascular diseases].
    Golay A
    Schweiz Rundsch Med Prax; 1992 Jan; 81(3):45-8. PubMed ID: 1733002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes.
    Krotkiewski M
    Scand J Rehabil Med Suppl; 1983; 9():55-70. PubMed ID: 6372078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid metabolism disorders and diabetes mellitus].
    Gries FA; Oberdisse K
    Dtsch Med Wochenschr; 1970 Apr; 95(14):727-34. PubMed ID: 4985349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tests for evaluating insulin sensitivity in vivo].
    Majkowska L
    Przegl Lek; 1999; 56(5):351-6. PubMed ID: 10554572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A
    Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal response and adaptation to short-term exercise and training].
    Guézennec CY
    Bull Acad Natl Med; 1995 Oct; 179(7):1449-57; discussion 1458-9. PubMed ID: 8556419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 19. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.